| Literature DB >> 35599726 |
Su-Peng Loh1, Shi-Hui Cheng2, Wael Mohamed3,4.
Abstract
Cognitive enhancement is defined as the augmentation of the mind's core capabilities through the improvement of internal or external information processing systems. Recently, the focus has shifted to the potential therapeutic effects of natural products in improving cognitive function. Edible bird's nest (EBN) is a natural food substance derived from the saliva of swiftlets. Until today, EBN is regarded as a high-priced nutritious food with therapeutic effects. The effectiveness of dietary EBN supplementation to enhance brain development in mammals has been documented. Although the neuroprotection of EBN has been previously reported, however, the impact of EBN on learning and memory control and its potential as a cognitive enhancer drug remains unknown. Thus, this article aims to address the neuroprotective benefits of EBN and its potential effect as a cognitive enhancer. Notably, the current challenges and the future study direction in EBN have been demonstrated.Entities:
Keywords: cognitive enhancers; dementia; dietary; edible bird's nest; neuroprotection
Year: 2022 PMID: 35599726 PMCID: PMC9120600 DOI: 10.3389/fneur.2022.865671
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Summary of some promising cognition-enhancing natural substances.
|
|
|
|
|
|---|---|---|---|
| Bacopa monniera ( | Facilitation of memory retention. Alleviation of the symptoms of anxiety and convulsive disorders. Powerful antioxidant actions. | Although the plant contains a variety of biologically active ingredients, including alkaloids, saponins, and sterols, the triterpenoid saponins known as “bacosides” are responsible for the memory-enhancing properties. | • Bacopa has been shown to have antioxidant qualities ( |
| Fava beans ( | The L-dopa found in Fava beans promotes memory, energy, a sense of wellbeing, and sexual drive, as well as aids in the treatment of Parkinson's Disease symptoms. | Fava beans has high concentrations of L-dopa, an amino acid that is enzymatically converted to the neurotransmitter dopamine. | • For 12 weeks, Parkinson's disease patients were given fava bean seed powder, while a control group received synthetic therapies. According to the Unified Parkinson's Disease Rating Scale, Fava Beans were beneficial with few unwanted effects ( |
| Ashwagandha ( | Ashwagandha is said to possess anti-inflammatory, anticancer, anti-stress, antioxidant, cognitive enhancing, and rejuvenating qualities. | Ashwagandha contains flavonoids and withanolide-class active compounds. Ashwagandha exhibits GABA-like activity (anxiolityc activity) and has been shown to raise the brain's acetylcholine level (cognition enhancement). | • According to study, ashwagandha increases the growth of axons and dendrites and the quantity of antioxidants in the brain ( |
| Celastrus paniculatus (CP) ( | Cognitive enhancing effect and powerful antioxidant activities are attributed to extracts of CP | Although some evidence suggests that the active compounds in CP (Bacosides A and B) reduce the activity of norepinephrine, dopamine, and serotonin, the mechanism by which CP exerts its cognitive effect is not completely understood. | • Chronic administration of seeds of CP to rats selectively corrected the deficit in spatial memory caused by scopolamine ( |
| Origanum majorana | Acetylcholinesterase (AChE) inhibitors, both natural and synthetic, increase the cholinergic tone in the brain and are beneficial in Alzheimer's disease and cognitive enhancement. | Ursolic acid, one of the active ingredients of origanum majorana (OM) and other Labiatae family herbs, is a highly effective natural AChE inhibitor ( | • Ursolic acid demonstrated antioxidant action, reducing Abeta neurotoxicity in rat's brain ( |
| Alpha lipoic acid (ALPA, thioctic acid) | Enhances memory by healing oxidative stress-induced cell damage and protects neurons from oxygen deprivation and poor blood flow. | Increases glutathione, vitamin C, and E levels and reduces reactive oxidant concentrations. Additionally, it decreases glucose levels and protects the mitochondria ( | • Double blind placebo-controlled trials demonstrate the antioxidant efficacy in the treatment of several types of poisoning ( |
Summary of studied effects of edible bird's nest (EBN) extract related to cognition.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Antioxidant effect | Water extraction | Human neuroblastoma cell (SH-SY5Y) | 1,000 μg/ml | EBN demonstrated protective effects against hydrogen peroxide-induced toxicity and cell oxidative stress on SH-SY5Y cells. Lactoferrin and ovotransferrin also possess antioxidant capacities on SH-SY5Y cells | • EBN and its ingredients reduced hydrogen peroxide-induced cytotoxicity, and decreased ROS by increasing scavenging activity. | ( |
| Water extraction | Human hepatocellular liver carcinoma (HepG2) cells | 1,000 μg/mL | EBN extracts were non-toxic to HEPG2 cells, and EBN extracts protected HEPG2 cells from hydrogen peroxide induced-toxicity. | • EBN and its ingredients reduced hydrogen peroxide-induced cytotoxicity, and digested EBN samples had significantly enhanced antioxidant activities | ( | |
| Powder | Rat model-high fat diet (HFD)was fed to rats for 12 weeks and compared with HFD + Simvastatin and HFD + EBN (2.5 or 20 %) | EBN (2.5 or 20 %) | C-reactive protein (CRP), interleukin (IL) 6 and tumor necrosis factor alpha (Tnf-α) were decreased in the EBN and Simvastatin groups. | • EBN reduced oxidative stress and inflammation due to high fat diet via modulating hepatic antioxidant and inflammation-related genes, and its results were superior than Simvastatin. Suggested active ingredient: sialic acid, lactoferrin and ovotransferrin | ( | |
| Water extraction | HepG2 cells and human normal lung (MRC-5) cells | 800 μg/mL | • EBN peptides showed a protective effect on H2O2-induced HepG2 cells by increasing cell viabilities up to 91.44 and 92.31%, respectively. | • The protective effect of EBN is mainly caused by peptides' scavenging ability of H2O2 radicals | ( | |
| Powder |
| food medium supplemented with 0 g/kg (control), 1, 3, and 9 g/kg of EBN | Results of ferric reducing antioxidant power (FRAP) showed that the EBN-treated groups had higher total antioxidant activity in a dose-dependent manner as compared to control | • EBN enhanced the antioxidant capacity by increasing the SOD and catalase activities (CAT) whereas the MDA level was decreased. | ( | |
| Powder | Rat | 30, 60, and 120 mg/kg body weight of EBN | EBN supplemented groups had normal uterine structures and higher morphological parameters of uteri than the control, despite exposure to lead acetate toxicity. SOD levels were also increased in EBN supplemented groups | • EBN reduce the effects of LA toxicity on the uterus by increasing enzymatic antioxidant (SOD) activity as well as expressions of cell proliferation factors such as epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and proliferating cell nuclear antigen (PCNA). | ( | |
| Neuroprotective effect | Water extraction | Human neuroblastoma cell (SH-SY5Y) | 0 to 500 μg/ml | EBN treatment lowers the level of 6- hydroxydopamine- induced apoptosis in SH-SY5Y cells, as evidenced by morphological and nuclear staining data | • EBN treatment reduces the level of 6- hydroxydopamine- induced apoptotic changes in SH-SY5Y cells that was revealed by morphological and nuclear staining observations | ( |
| Water extraction | Human neuroblastoma cell (SH-SY5Y) | 1,000 μg/ml | EBN and its content (lactoferrin and ovotransferrin) enhanced scavenging activity by reducing H2O2- induced cytotoxicity and decreasing radical oxygen species | • EBN acts as a neuroprotective (SH- SY5Y human neuroblastoma cell) agent against H2O2- induced cytotoxicity and cell oxidative stress | ( | |
| Powder | Ovariectomized rats | 1.2, 0.6, and 0.3 g/kg body weight | EBN and estrogen enhanced spatial learning and memory and increased serum estrogen and hippocampal sirtuin-1 (SIRT1) expression, and EBN groups did not show as much toxicity to the liver as the estrogen group | • The effect of EBN in improving cognition and memory in ovariectomized rats is probably mediated by enhancing the SIRT1-mediated neuronal plasticity | ( | |
| Alcohol extraction | 2VO rat model | 60 mg/kg, 120 mg/kg | EBN demonstrated neuroprotective effects especially for Hippocampus CA1 area | • They underscored the neuroprotective effects of EBN with brain ischemia in rat animal model | ( | |
| Powder | Wistar rats | 125 mg/kg, 250 mg/kg, and 500 mg/kg | Treatment with EBN inhibited the LPS-induced upregulation of proinflammatory cytokines (TNF-α, IL-1β, and IL-6) and oxidative markers (ROS and TBARS) in the hippocampus. | • Anti-inflammatory effect by EBN may be attributed to sialic acid content | ( | |
| Powder | ICR mice | 9 g dry EBN in every 182 g water | administration with EBN in maternal mice during pregnancy or lactation period can improve the learning and memory functions in their offspring | • Maternal EBN administration improved the spatial learning in the offspring by increasing SOD and choline acetyltransferase (ChAT) activity and, decreasing the levels of MDA and activities of acetylcholinesterase (AChE). Moreover, BDNF levels for CA1, CA2, and CA3 regions in hippocampi and the numbers of dyed neurons in CA1, CA2, CA3, and DG regions among the offspring were significantly enhanced. | ( | |
| Water extraction | CJ57B/6 breeder's mice | 10 mg/kg body weight | Dietary EBN supplementation showed an upregulation of GNE, ST8SiaIV, SLC17A5, and BDNF mRNA associated with an improvement in Y-maze cognitive performance in both generations of the animal. | • EBN supplementation improved the learning and memory function of F1 and F2 mice in the Y-maze test by increasing brain gene expression and synaptic vesicle densities | ( | |
| Water extraction | BALB/c mice | 20, 40, 60, 80, and 100 μg/ml sialic acid | Sialic acid extract and sialic acid standard at 60 μg/mL (0.6 ppm) increased cell viability and showed no cytotoxicity effects in pheochromocytoma and neuroblastoma cell lines. An administration of higher dose of sialic acid at 0.6 ppm in animals improved Y-maze test performance | • The presence of epidermal growth factor-like activity in sialic acid extract from EBN play a key role in growth-stimulating normal cellular processes such as proliferation, differentiation, and development. | ( | |
| Powder | Ovariectomized rats | 6, 3, and 1.5% EBN | EBNs significantly decreased estrogen deficiency-associated serum elevation of advanced glycation end-products (AGEs), and they changed redox status as evidenced by oxidative damage (MDA content) and enzymatic antioxidant defense (SOD and catalase) markers | • EBN has potential for neuroprotection against estrogen deficiency-associated senescence, by decreasing serum AGEs, reducing hippocampal and frontal cortical caspase 3 protein and MDA levels, and balancing activities of anti-oxidant enzymes in the hippocampus and frontal cortex of ovariectomized female rats | ( |